List of Tables
Summary Table B: Global Market for Liquid Biopsy, by Region, Through 2029
Summary Table A: Global Market for Liquid Biopsy, by Application, Through 2029
Table 1: Liquid Biopsy Sample Types and Characteristics
Table 2: Types of Analytes Used in Liquid Biopsy
Table 3: Comparison of ctDNA/cfDNA and CTCs
Table 4: List of Some Liquid Biopsy-based Available Tests Approved by FDA/CE-IVD
Table 5: Global Cancer Incidence and Mortality Cases, by WHO Region, 2022
Table 6: Emerging ctDNA and CTC Technologies for Liquid Biopsies
Table 7: List of Clinical Trials Conducted in Liquid Biopsies
Table 8: Global Market for Liquid Biopsy, by Application, Through 2029
Table 9: Global Market for Liquid Biopsy for NIPT, by Region, Through 2029
Table 10: Global Market for Liquid Biopsy for Cancer, by Region, Through 2029
Table 11: Global Market for Liquid Biopsy for Organ Transplantation, by Region, Through 2029
Table 12: Global Market for Liquid Biopsy, by Purpose of Analysis, Through 2029
Table 13: Global Market for Liquid Biopsy for Early Detection/Screening, by Region, Through 2029
Table 14: Global Market for Liquid Biopsy for Monitoring, by Region, Through 2029
Table 15: Global Market for Liquid Biopsy for Diagnosis, by Region, Through 2029
Table 16: Global Market for Liquid Biopsy for Therapy Guidance, by Region, Through 2029
Table 17: Global Market for Liquid Biopsy, by Biomarker Type, Through 2029
Table 18: Global Market for Liquid Biopsy for Cell-free Nucleic Acids, by Region, Through 2029
Table 19: Global Market for Liquid Biopsy for Circulating Tumor Cells, by Region, Through 2029
Table 20: Global Market for Liquid Biopsy for Other Biomarker Types, by Region, Through 2029
Table 21: Global Market for Liquid Biopsy, by Analysis Platform, Through 2029
Table 22: Global Market for Liquid Biopsy for Next-Generation Sequencing, by Region, Through 2029
Table 23: Global Market for Liquid Biopsy for Polymerase Chain Reaction, by Region, Through 2029
Table 24: Global Market for Liquid Biopsy for Other Analysis Platforms, by Region, Through 2029
Table 25: Global Market for Liquid Biopsy, by Cancer Site, Through 2029
Table 26: Global Market for Liquid Biopsy for Pan-Cancer, by Region, Through 2029
Table 27: Global Market for Liquid Biopsy for Colorectal Cancer, by Region, Through 2029
Table 28: Global Market for Liquid Biopsy for Breast Cancer, by Region, Through 2029
Table 29: Global Market for Liquid Biopsy for Lung Cancer, by Region, Through 2029
Table 30: Global Market for Liquid Biopsy for Bladder Cancer, by Region, Through 2029
Table 31: Global Market for Liquid Biopsy for Prostate Cancer, by Region, Through 2029
Table 32: Global Market for Liquid Biopsy for Hematologic Cancer, by Region, Through 2029
Table 33: Global Market for Liquid Biopsy for Gynecologic Cancer, by Region, Through 2029
Table 34: Global Market for Liquid Biopsy for Other Cancers, by Region, Through 2029
Table 35: Global Market for Liquid Biopsy, by Region, Through 2029
Table 36: North American Market for Liquid Biopsy, by Application, Through 2029
Table 37: North American Market for Liquid Biopsy, by Purpose of Analysis, Through 2029
Table 38: North American Market for Liquid Biopsy, by Biomarker Type, Through 2029
Table 39: North American Market for Liquid Biopsy, by Analysis Platform, Through 2029
Table 40: North American Market for Liquid Biopsy, by Cancer Site, Through 2029
Table 41: Estimated Incidence of Cancer Cases in the EU, by Country, 2022
Table 42: European Research Initiatives Focused on Personalized Medicine
Table 43: European Market for Liquid Biopsy, by Application, Through 2029
Table 44: European Market for Liquid Biopsy, by Purpose of Analysis, Through 2029
Table 45: European Market for Liquid Biopsy, by Biomarker Type, Through 2029
Table 46: European Market for Liquid Biopsy, by Analysis Platform, Through 2029
Table 47: European Market for Liquid Biopsy, by Cancer Site, Through 2029
Table 48: Asia-Pacific Market for Liquid Biopsy, by Application, Through 2029
Table 49: Asia-Pacific Market for Liquid Biopsy, by Purpose of Analysis, Through 2029
Table 50: Asia-Pacific Market for Liquid Biopsy, by Biomarker Type, Through 2029
Table 51: Asia-Pacific Market for Liquid Biopsy, by Analysis Platform, Through 2029
Table 52: Asia-Pacific Market for Liquid Biopsy, by Cancer Site, Through 2029
Table 53: RoW Market for Liquid Biopsy, by Application, Through 2029
Table 54: RoW Market for Liquid Biopsy, by Purpose of Analysis, Through 2029
Table 55: RoW Market for Liquid Biopsy, by Biomarker Type, Through 2029
Table 56: RoW Market for Liquid Biopsy, by Analysis Platform, Through 2029
Table 57: RoW Market for Liquid Biopsy, by Cancer Site, Through 2029
Table 58: Leading Companies in the Liquid Biopsy Market, 2023
Table 59: Comparison of Liquid Biopsy Tests for Early Detection of Single Cancers
Table 60: Key Focus Areas in ESG Metrics
Table 61: Environmental Performance Initiatives in the Liquid Biopsy Market
Table 62: Social Performance Initiatives in the Liquid Biopsy Market
Table 63: Governance Performance Initiatives in the Liquid Biopsy Market
Table 64: ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
Table 65: Abbreviations Used in this Report
Table 66: Bio-Rad Laboratories Inc.: Company Snapshot
Table 67: Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68: Bio-Rad Laboratories Inc.: Product Portfolio
Table 69: Bio-Rad Laboratories Inc.: News/Key Developments, 2022-2024
Table 70: Bio-Techne: Company Snapshot
Table 71: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 72: Bio-Techne: Product Portfolio
Table 73: Bio-Techne: News/Key Developments, 2023 and 2024
Table 74: Dxcover Ltd.: Company Snapshot
Table 75: Dxcover Ltd.: Product Portfolio
Table 76: Dxcover Ltd.: News/Key Developments, 2023 and 2024
Table 77: Exact Sciences Corp.: Company Snapshot
Table 78: Exact Sciences Corp.: Financial Performance, FY 2022 and 2023
Table 79: Exact Sciences Corp.: Product Portfolio
Table 80: Exact Sciences Corp.: News/Key Developments, 2022-2024
Table 81: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82: F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83: F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84: F. Hoffman-La Roche Ltd.: News/Key Developments, 2021-2023
Table 85: Freenome Holdings Inc.: Company Snapshot
Table 86: Freenome Holdings Inc.: Product Portfolio
Table 87: Freenome Holdings Inc.: News/Key Developments, 2023 and 2024
Table 88: Guardant Health: Company Snapshot
Table 89: Guardant Health: Financial Performance, FY 2022 and 2023
Table 90: Guardant Health: Product Portfolio
Table 91: Guardant Health: News/Key Developments, 2022-2024
Table 92: Illumina Inc.: Company Snapshot
Table 93: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 94: Illumina Inc.: Product Portfolio
Table 95: Illumina Inc.: News/Key Developments, 2022 and 2023
Table 96: Myriad Genetics Inc.: Company Snapshot
Table 97: Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023
Table 98: Myriad Genetics Inc: Product Portfolio
Table 99: Myriad Genetics Inc.: News/Key Developments, 2022-2024
Table 100: Natera Inc.: Company Snapshot
Table 101: Natera Inc.: Financial Performance, FY 2022 and 2023
Table 102: Natera Inc: Product Portfolio
Table 103: NeoGenomics Laboratories: Company Snapshot
Table 104: NeoGenomics Laboratories: Financial Performance, FY 2022 and 2023
Table 105: NeoGenomics Laboratories: Product Portfolio
Table 106: NeoGenomics Laboratories: News/Key Developments, 2022-2024
Table 107: Novigenix SA: Company Snapshot
Table 108: Novigenix SA: Product Portfolio
Table 109: Novigenix SA: News/Key Developments, 2024
Table 110: Personalis Inc.: Company Snapshot
Table 111: Personalis Inc.: Financial Performance, FY 2022 and 2023
Table 112: Personalis Inc.: Product Portfolio
Table 113: Personalis Inc.: News/Key Developments, 2023 and 2024
Table 114: QIAGEN: Company Snapshot
Table 115: QIAGEN: Financial Performance, FY 2022 and 2023
Table 116: QIAGEN: Product Portfolio
Table 117: QIAGEN: News/Key Developments, 2023 and 2024
Table 118: Thermo Fisher Scientific Inc.: Company Snapshot
Table 119: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 120: Thermo Fisher Scientific Inc.: Product Portfolio
Table 121: Thermo Fisher Scientific Inc.: News/Key Developments, 2022
List of Figures
Summary Figure A: Global Market for Liquid Biopsy, by Application, 2021-2029
Summary Figure B: Global Market for Liquid Biopsy, by Region, 2021-2029
Figure 1: Snapshot of the Market Dynamics for Liquid Biopsy
Figure 2: Global Market Shares of Liquid Biopsy, by Application 2024
Figure 3: Global Market for Liquid Biopsy for NIPT, by Region, 2021-2029
Figure 4: Estimated Number of New Cancer Cases Globally, 2022, 2045 and 2050
Figure 5: Global Market for Liquid Biopsy for Cancer, by Region, 2021-2029
Figure 6: Global Market for Liquid Biopsy for Organ Transplantation, by Region, 2021-2029
Figure 7: Global Market Shares of Liquid Biopsy, by Purpose of Analysis, 2024
Figure 8: Global Market for Liquid Biopsy for Early Detection/Screening, by Region, 2021-2029
Figure 9: Global Market for Liquid Biopsy for Monitoring, by Region, 2021-2029
Figure 10: Global Market for Liquid Biopsy for Monitoring, by Region, 2021-2029
Figure 11: Global Market for Liquid Biopsy for Therapy Guidance, by Region, 2021-2029
Figure 12: Global Market Shares of Liquid Biopsy, by Biomarker Type, 2024
Figure 13: Global Market for Liquid Biopsy for Cell-free Nucleic Acids, by Region, 2021-2029
Figure 14: Global Market for Liquid Biopsy for Circulating Tumor Cells, by Region, 2021-2029
Figure 15: Global Market for Liquid Biopsy for Other Biomarker Types, by Region, 2021-2029
Figure 16: Global Market Shares of Liquid Biopsy, by Analysis Platform, 2024
Figure 17: Global Market for Liquid Biopsy for Next-Generation Sequencing, by Region, 2021-2029
Figure 18: Global Market for Liquid Biopsy for Polymerase Chain Reaction, by Region, 2021-2029
Figure 19: Global Market for Liquid Biopsy for Other Analysis Platforms, by Region, 2021-2029
Figure 20: Global Market Shares of Liquid Biopsy, by Cancer Site, 2024
Figure 21: Global Market for Liquid Biopsy for Pan-Cancer, by Region, 2021-2029
Figure 22: Global Market for Liquid Biopsy for Colorectal Cancer, by Region, 2021-2029
Figure 23: Global Market for Liquid Biopsy for Breast Cancer, by Region, 2021-2029
Figure 24: Global Market for Liquid Biopsy for Lung Cancer, by Region, 2021-2029
Figure 25: Global Market for Liquid Biopsy for Bladder Cancer, by Region, 2021-2029
Figure 26: Global Market for Liquid Biopsy for Prostate Cancer, by Region, 2021-2029
Figure 27: Global Market for Liquid Biopsy for Hematologic Cancer, by Region, 2021-2029
Figure 28: Global Market for Liquid Biopsy for Gynecologic Cancer, by Region, 2021-2029
Figure 29: Global Market for Liquid Biopsy for Other Cancers, by Region, 2021-2029
Figure 30: Global Market Shares of Liquid Biopsy, by Region, 2024
Figure 31: U.S. Elderly Population (65 and Older), 2010-2050
Figure 32: North American Market for Liquid Biopsy, by Application, 2021-2029
Figure 33: North American Market for Liquid Biopsy, by Purpose of Analysis, 2021-2029
Figure 34: North American Market for Liquid Biopsy, by Biomarker Type, 2021-2029
Figure 35: North American Market for Liquid Biopsy, by Analysis Platform, 2021-2029
Figure 36: North American Market for Liquid Biopsy, by Cancer Site, 2021-2029
Figure 37: European Market for Liquid Biopsy, by Application, 2021-2029
Figure 38: European Market for Liquid Biopsy, by Purpose of Analysis, 2021-2029
Figure 39: European Market for Liquid Biopsy, by Biomarker Type, 2021-2029
Figure 40: European Market for Liquid Biopsy, by Analysis Platform, 2021-2029
Figure 41: European Market for Liquid Biopsy, by Cancer Site, 2021-2029
Figure 42: Asia-Pacific Market for Liquid Biopsy, by Application, 2021-2029
Figure 43: Asia-Pacific Market for Liquid Biopsy, by Purpose of Analysis, 2021-2029
Figure 44: Asia-Pacific Market for Liquid Biopsy, by Biomarker Type, 2021-2029
Figure 45: Asia-Pacific Market for Liquid Biopsy, by Analysis Platform, 2021-2029
Figure 46: Asia-Pacific Market for Liquid Biopsy, by Cancer Site, 2021-2029
Figure 47: RoW Market for Liquid Biopsy, by Application, 2021-2029
Figure 48: RoW Market for Liquid Biopsy, by Purpose of Analysis, 2021-2029
Figure 49: RoW Market for Liquid Biopsy, by Biomarker Type, 2021-2029
Figure 50: RoW Market for Liquid Biopsy, by Analysis Platform, 2021-2029
Figure 51: RoW Market for Liquid Biopsy, by Cancer Site, 2021-2029
Figure 52: How a Strong ESG Proposition Benefits Businesses?
Figure 53: Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 54: Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 55: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 56: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 57: Exact Sciences Corp.: Revenue Share, by Business Unit, FY 2023
Figure 58: Exact Sciences Corp.: Revenue Share, by Country/Region, FY 2023
Figure 59: F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 60: F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 61: Guardant Health: Revenue Share, by Business Unit, FY 2023
Figure 62: Guardant Health: Revenue Share, by Country/Region, FY 2023
Figure 63: Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 64: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 65: Myriad Genetics Inc.: Revenue Share, by Business Unit, FY 2023
Figure 66: Myriad Genetics Inc.: Revenue Share, by Country/Region, FY 2023
Figure 67: Natera Inc.: Revenue Share, by Country/Region, FY 2023
Figure 68: NeoGenomics Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 69: Personalis Inc.: Revenue Share, by Business Unit, FY 2023
Figure 70: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 71: QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 72: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 73: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
